晚期纤维化与非酒精性脂肪性肝病患者新发心血管疾病相关
这项前瞻性队列研究纳入285例经活检证实、无心血管疾病的非酒精性脂肪性肝病(NAFLD)成人,中位随访5.2年,26/285(9.1%)发生新发心血管事件。活检晚期纤维化(3-4期)是多变量分析中的独立预测因素(SHR 2.86,95%CI 1.36-6.04),NAFLD纤维化评分是唯一独立的非侵入性纤维化预测指标。
要点
- 活检证实的晚期纤维化(3-4期)独立预测NAFLD患者新发心血管事件。
- NAFLD纤维化评分是唯一独立的非侵入性纤维化预测指标。
- 脂肪性肝炎等其他组织学特征与新发心血管疾病无关。
核心结论
- 在活检证实的NAFLD成人中,活检晚期纤维化和较高的NAFLD纤维化评分是新发心血管疾病的显著独立预测因素,即使考虑传统危险因素和心血管风险评分后仍成立。
研究设计与样本
- 2011至2018年前瞻性纳入活检证实NAFLD且无心血管疾病的成人,随访至首次记录新发心血管疾病、死亡或随访结束(2018年11月1日),采用竞争风险分析。
- 共285例,中位随访5.2年。
主要发现
- 26/285(9.1%)个体在中位随访5.2年内发生新发心血管事件。
- 活检晚期纤维化(3-4期)预测新发心血管疾病,多变量分析SHR 2.86(95%CI 1.36-6.04)。
- 心血管风险评分不是独立预测因素。
- NAFLD纤维化评分是唯一独立的非侵入性纤维化预测指标。
- 脂肪性肝炎等其他组织学特征与新发心血管疾病无关。
临床怎么用
- 评估NAFLD患者心血管疾病一级预防时,应考虑活检晚期纤维化和NAFLD纤维化评分。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is associated with an increased risk of cardiovascular disease. It is not well understood, however, which individuals with NAFLD are at highest risk for cardiovascular disease. AIMS: To determine the factors associated with incident cardiovascular events in a prospective cohort of individuals with biopsy-proven NAFLD without pre-existing cardiovascular disease. METHODS: From 2011 to 2018, adults with biopsy-proven NAFLD without cardiovascular disease were enrolled in a tissue repository and were followed prospectively to the first recorded date of incident cardiovascular disease, death or the end of follow-up (11/1/2018). Competing risks analysis was performed to identify predictors of incident cardiovascular disease. RESULTS: After a median follow-up time of 5.2 years, 26/285 (9.1%) individuals experienced an incident cardiovascular event. Advanced fibrosis (stage 3-4) on biopsy was a significant predictor of incident cardiovascular disease, and this persisted on multivariable analysis (SHR 2.86, 95% CI 1.36-6.04) after considering relevant covariates, including cardiovascular risk scores, which were not independent predictors. Of the non-invasive indicators of fibrosis, the NAFLD fibrosis score was the only independent predictor of cardiovascular disease. Other histologic features, including steatohepatitis, were not associated with incident cardiovascular disease. CONCLUSIONS: In adults with biopsy-proven NAFLD, advanced fibrosis on biopsy and higher NAFLD fibrosis score were significant and independent predictors of incident cardiovascular disease, even after considering traditional risk factors and cardiovascular risk scores. These findings should be considered when evaluating NAFLD patients for primary prevention of cardiovascular disease, and further evaluation into the link between advanced fibrosis and cardiovascular disease is needed.
引用
- Henson JB, Simon TG, Kaplan A, et al. Advanced fibrosis is associated with incident cardiovascular disease in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther. 2020. PMID: 32043602. doi:10.1111/apt.15660
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。